Skip to main content
S 741 116th Congress Senate Health Cancer Drug therapy Health care costs and insurance Health care coverage and access Prescription drugs

Cancer Drug Parity Act of 2019

Introduced: March 12, 2019 Introduced by: Smith, Tina Democratic · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 12, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cancer Drug Parity Act of 2019

This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
What's happening now March 12, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 1730 Identical bill Cancer Drug Parity Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 17
All 17 Democratic 7 Republican 10
R
Scott, Rick
Florida · Sep 30, 2020
 R
Capito, Shelley Moore
West Virginia · Jul 10, 2019
 D
Whitehouse, Sheldon
Rhode Island · Jul 10, 2019
 R
Blackburn, Marsha
Tennessee · May 21, 2019
 D
Merkley, Jeff
Oregon · May 21, 2019
 D
Baldwin, Tammy
Wisconsin · May 6, 2019
 R
Cramer, Kevin
North Dakota · May 6, 2019
 D
Blumenthal, Richard
Connecticut · Apr 29, 2019
 R
Collins, Susan M.
Maine · Apr 29, 2019
 R
Boozman, John
Arkansas · Apr 1, 2019
 D
Markey, Edward J.
Massachusetts · Apr 1, 2019
 R
Hyde-Smith, Cindy
Mississippi · Mar 27, 2019
 D
Klobuchar, Amy
Minnesota · Mar 27, 2019
 R
Murkowski, Lisa
Alaska · Mar 25, 2019
 R
Moran, Jerry
Kansas · Mar 12, 2019
 D
Murphy, Christopher
Connecticut · Mar 12, 2019
 R
Wicker, Roger F.
Mississippi · Mar 12, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 741: Cancer Drug Parity Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-741/
MLA
"S. 741: Cancer Drug Parity Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-741/.
Bluebook (legal)
S. 741, 116th Cong. (2026), https://openamerica.io/bill/116-S-741/.
Markdown link
[S. 741: Cancer Drug Parity Act of 2019](https://openamerica.io/bill/116-S-741/)
Report a problem